The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Morozova M.A.

Centre for Mental Health Research

Nikonova E.Yu.

Lomonosov Moscow State University

Ashurova G.Ch.

Branch of the Psychiatric Clinical Hospital No. 4 named after P.B. Gannushkin, Psychoneurological Dispensary No. 4

Trushkova V.V.

Branch of the Psychiatric Clinical Hospital No. 4 named after P.B. Gannushkin, Psychoneurological Dispensary No. 4

Radchenko A.Yu.

Branch of the Psychiatric Clinical Hospital No. 4 named after P.B. Gannushkin, Psychoneurological Dispensary No. 4

Petukhova N.S.

Branch of the Psychiatric Clinical Hospital No. 4 named after P.B. Gannushkin, Psychoneurological Dispensary No. 4

Rupchev G.E.

Centre for Mental Health Research;
Lomonosov Moscow State University

The effect of psychopharmacological load on various aspects of the condition in patients with depressive syndrome during remission

Authors:

Morozova M.A., Nikonova E.Yu., Ashurova G.Ch., Trushkova V.V., Radchenko A.Yu., Petukhova N.S., Rupchev G.E.

More about the authors

Read: 711 times


To cite this article:

Morozova MA, Nikonova EYu, Ashurova GCh, Trushkova VV, Radchenko AYu, Petukhova NS, Rupchev GE. The effect of psychopharmacological load on various aspects of the condition in patients with depressive syndrome during remission. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(11):69‑76. (In Russ.)
https://doi.org/10.17116/jnevro202512511169

Recommended articles:
Factors of depression acco­rding to acti­graphy in the fall season. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):27-32
Identification of depression biomarkers: Prospects for use in clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):51-55
Depression Anxiety Stress Scale (russian language version). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):103-107
Modern concepts of sleep disturbances asso­ciated with mental diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):7-12
Factors supporting chro­nic inflammation in mental illness. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):7-15
Dysfunctional pelvic pain in women. Russian Journal of Pain. 2025;(2):32-37

References:

  1. Danilov DS. Depression therapy optimization at the present stage of development of psychopharmacology. Nevrologiya, neiropsikhiatriya, psikhosomatika. 2013;5(1):22-27. (In Russ.). https://doi.org/10.14412/2074-2711-2013-2393
  2. Usov GM. Diagnosis and treatment of depression according to the functional recovery paradigm. Nevrologiya, neiropsikhiatriya, psikhosomatika. 2023;15(5):79-86. (In Russ.). https://doi.org/10.14412/2074-2711-2023-5-79-86
  3. Rafeyan R, Papakostas GI, Jackson WC, et al. Inadequate Response to Treatment in Major Depressive Disorder: Augmentation and Adjunctive Strategies. J Clin Psychiatry. 2020;81(3):OT19037BR3. https://doi.org/10.4088/JCP.OT19037BR3
  4. Dodd S, Bauer M, Carvalho AF, et al. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don’t work well enough? World J Biol Psychiatry. 2021 Sep;22(7):483-494.  https://doi.org/10.1080/15622975.2020.1851052
  5. Shmukler AB. The importance of cognitive impairments in assessing the pathogenesis, clinical presentation, and treatment of depression. Sotsial’naya i klinicheskaya psikhiatriya. 2016a;26(4):57-62. (In Russ.).
  6. Shmukler AB. Cognitive impairments in the structure of depressive syndrome. Sotsial’naya i klinicheskaya psikhiatriya. 2016b;26(1):72-76. (In Russ.).
  7. Oleichik IV, Shishkovskaia TI, Baranov PA. Contemporary approaches to correction of cognitive impairment in endogenous depression. V.M. Bekhterev review of psychiatry and medical psychology. 2020;(4):82-93. (In Russ.). https://doi.org/10.31363/2313-7053-2020-4-82-93
  8. Vanek J, Prasko J, Genzor S, et al. Obstructive sleep apnea, depression and cognitive impairment. Sleep Med. 2020 Aug;72:50-58.  https://doi.org/10.1016/j.sleep.2020.03.017
  9. Czerwińska A, Pawłowski T. Cognitive dysfunctions in depression — significance, description and treatment prospects. Psychiatr Pol. 2020;54(3):453-466.  https://doi.org/10.12740/PP/OnlineFirst/105415
  10. Nagane A, Baba H, Nakano Y, et al. Comparative study of cognitive impairment between medicated and medication-free patients with remitted major depression: class-specific influence by tricyclic antidepressants and newer antidepressants. Psychiatry Res. 2014;218(1-2):101-105.  https://doi.org/10.1016/j.psychres.2014.04.013
  11. Senna S, Schwab B, Melo HM, et al. Social cognition and suicide-related behaviors in depression: a cross-sectional, exploratory study. Braz J Psychiatry. 2022;44(6):639-643.  https://doi.org/10.47626/1516-4446-2021-2407
  12. Abraham E, Wang Y, Svob C, et al. Organization of the social cognition network predicts future depression and interpersonal impairment: a prospective family-based study. Neuropsychopharmacology. 2022;47(2):531-542.  https://doi.org/10.1038/s41386-021-01065-8
  13. Tekin U, Erermiş HS, Satar A, et al. Social cognition in first episode adolescent depression and its correlation with clinical features and quality of life. Clin Child Psychol Psychiatry. 2021;26(1):140-153.  https://doi.org/10.1177/1359104520973254
  14. Kajimura N, Mizuki Y, Kai S, et al. Memory and cognitive impairments in a case of long-term trihexyphenidyl abuse. Pharmacopsychiatry. 1993;26(2):59-62.  https://doi.org/10.1055/s-2007-1014343
  15. Pehrson AL, Leiser SC, Gulinello M, et al. Treatment of cognitive dysfunction in major depressive disorder — a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine. Eur J Pharmacol. 2015;753:19-31.  https://doi.org/10.1016/j.ejphar.2014.07.044
  16. Prado CE, Watt S, Crowe SF. A meta-analysis of the effects of antidepressants on cognitive functioning in depressed and non-depressed samples. Neuropsychol Rev. 2018;28(1):32-72.  https://doi.org/10.1007/s11065-018-9369-5
  17. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62.  https://doi.org/10.1136/jnnp.23.1.56
  18. Hamilton M. The Assessment of Anxiety States by Rating. Br J Med Psychol. 1959;32(1):50-55.  https://doi.org/10.1136/jnnp.23.1.56
  19. Sarkisyan GR, Gurovich IYa, Keefe RS. Normative data for Russian statistics and standardization of the indicator «Brief Characteristic of Cognitive Functions in Patients with Schizophrenia» (BACS). Social’naya i klinicheskaya psihiatriya. 2010;3:13-19. (In Russ.).
  20. Morozova MA, Rupchev GE, Alekseev AA, et al. Latent Dysphoria in the Structure of Emotional Disorders in Patients with Functional Constipation [Elektronnyi resurs]. Klinicheskaia i spetsial’naia psikhologiia. 2021;10(4):68-92. (In Russ.). https://doi.org/10.17759/cpse.2021100404
  21. Morozova MA, Nikonova EYu, Rupchev GE, et al. Features of emotion attribution in the social context in patients with schizophrenia in remission with residual psychotic symptoms. Nacional’nyj psihologicheskij zhurnal. 2025;20(2):92-105. (In Russ.). https://doi.org/10.11621/npj.2025.0207
  22. Hayasaka Y, Purgato M, Magni LR, et al. Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. J Affect Disord. 2015;180:179-184.  https://doi.org/10.1016/j.jad.2015.03.021
  23. McAdam MK, Baldessarini RJ, Murphy AL, et al. Second International Consensus Study of Antipsychotic Dosing (ICSAD-2). J Psychopharmacol. 2023;37(10):982-991.  https://doi.org/10.1177/02698811231205688
  24. Gardner DM, Murphy AL, O’Donnell H, et al. International consensus study of antipsychotic dosing. Am J Psychiatry. 2010;167(6):686-693.  https://doi.org/10.1176/appi.ajp.2009.09060802
  25. Kenwood MM, Kalin N, Barbas H. The prefrontal cortex, pathological anxiety, and anxiety disorders. Neuropsychopharmacol. 2022;47:260-275.  https://doi.org/10.1038/s41386-021-01109-z
  26. Carter B, Strawbridge R, Husain MI, et al. Relative effectiveness of augmentation treatments for treatment-resistant depression: a systematic review and network meta-analysis. Int Rev Psychiatry. 2020;32:477-490. 
  27. Vázquez GH, Bahji A, Undurraga J, et al. Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium. J Psychopharmacol. 2021;35(8):890-900.  https://doi.org/10.1177/02698811211013579
  28. El-Khalili N, Joyce M, Atkinson S, et al. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study. Int J Neuropsychopharmacol. 2010;13(7):917-932.  https://doi.org/10.1017/S1461145710000015
  29. Pillinger T, Howes OD, Correll CU, et al. Antidepressant and antipsychotic side-effects and personalised prescribing: a systematic review and digital tool development. Lancet Psychiatry. 2023;10(11):860-876.  https://doi.org/10.1016/S2215-0366(23)00262-6
  30. Sinyor M, Schaffer A, Levitt A. The sequenced treatment alternatives to relieve depression (STAR*D) trial: a review. Can J Psychiatry. 2010;55(3):126-135.  https://doi.org/10.1177/070674371005500303
  31. Howland RH. The antidepressant effects of anticholinergic drugs. J Psychosoc Nurs Ment Health Serv. 2009;47(6):17-20.  https://doi.org/10.3928/02793695-20090508-01
  32. Drevets WC, Zarate CA Jr, Furey ML. Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review. Biol Psychiatry. 2013;73(12):1156-1163. https://doi.org/10.1016/j.biopsych.2012.09.031

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.